Literature DB >> 14711512

A novel multi-affinity tag system to produce high levels of soluble and biotinylated proteins in Escherichia coli.

S Salman Ashraf1, R Edward Benson, E Sturgis Payne, Cale M Halbleib, Hanne Grøn.   

Abstract

We describe here a novel multi-affinity tag vector that can be used to produce high levels of soluble, in vivo biotinylated proteins in Escherichia coli. This system combines the solubility-enhancing ability of maltose-binding protein (MBP), the versatility of the hexahistidine tag (His(6)), and the site-specific in vivo biotinylation of a 15-amino acid tag (AviTag). We used this multi-tag system in an attempt to improve expression levels of two prokaryotic proteins-elongation factor Tu (TufB) and DNA gyrase subunit A (GyrA)-as well as two eukaryotic nuclear receptors-glucocorticoid receptor (GR) and small heterodimer partner (SHP). The multi-tag system not only vastly improved the expression of the two prokaryotic proteins tested, but also yielded complete, site-specific, in vivo biotinylation of these proteins. The results obtained from the TufB expression and purification are presented and discussed in detail. The nuclear receptors, though soluble as fusion partners, failed to remain soluble once the MBP tag was cleaved. Despite this limitation of the system, the multi-affinity tag approach is a useful system that can improve expression of some otherwise insoluble or poorly expressing proteins, to obtain homogeneous, purified, fully biotinylated protein for downstream applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14711512     DOI: 10.1016/j.pep.2003.10.016

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  9 in total

1.  Development of a multifunctional tool for drug screening against plasmodial protein-protein interactions via surface plasmon resonance.

Authors:  Lauren E Boucher; Jürgen Bosch
Journal:  J Mol Recognit       Date:  2013-10       Impact factor: 2.137

2.  Effect of N-terminal solubility enhancing fusion proteins on yield of purified target protein.

Authors:  Martin Hammarström; Esmeralda A Woestenenk; Niklas Hellgren; Torleif Härd; Helena Berglund
Journal:  J Struct Funct Genomics       Date:  2006-07-19

3.  Purification of Antibacterial CHAPK Protein Using a Self-Cleaving Fusion Tag and Its Activity Against Methicillin-Resistant Staphylococcus aureus.

Authors:  Elahe Seyed Hosseini; Rezvan Moniri; Yasaman Dasteh Goli; Hamed Haddad Kashani
Journal:  Probiotics Antimicrob Proteins       Date:  2016-12       Impact factor: 4.609

4.  Specific binder for Lightning-Link® biotinylated proteins from an antibody phage library.

Authors:  Fortunato Ferrara; Leslie A Naranjo; Sara D'Angelo; Csaba Kiss; Andrew R M Bradbury
Journal:  J Immunol Methods       Date:  2013-07-11       Impact factor: 2.303

5.  High-throughput biotinylation of proteins.

Authors:  Brian K Kay; Sang Thai; Veronica V Volgina
Journal:  Methods Mol Biol       Date:  2009

6.  Platform for high-throughput antibody selection using synthetically-designed antibody libraries.

Authors:  Melissa Batonick; Erika G Holland; Valeria Busygina; Dawn Alderman; Brian K Kay; Michael P Weiner; Margaret M Kiss
Journal:  N Biotechnol       Date:  2015-11-24       Impact factor: 5.079

7.  Deconstruction of the beaten Path-Sidestep interaction network provides insights into neuromuscular system development.

Authors:  Hanqing Li; Ash Watson; Agnieszka Olechwier; Michael Anaya; Siamak K Sorooshyari; Dermott P Harnett; Hyung-Kook Peter Lee; Jost Vielmetter; Mario A Fares; K Christopher Garcia; Engin Özkan; Juan-Pablo Labrador; Kai Zinn
Journal:  Elife       Date:  2017-08-15       Impact factor: 8.140

8.  SnAvi--a new tandem tag for high-affinity protein-complex purification.

Authors:  Ursula Schäffer; Andreas Schlosser; Kristian M Müller; Angelika Schäfer; Nenad Katava; Ralf Baumeister; Ekkehard Schulze
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

Review 9.  Recombinant viral proteins for use in diagnostic ELISAs to detect virus infection.

Authors:  Kelly-Anne Spencer; Fernando A Osorio; Julian A Hiscox
Journal:  Vaccine       Date:  2007-03-06       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.